Federal contract award
FA252119FA405
4 FULL TIME EQUIVALENT PHARMACISTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | FA2521 45 CONS PK |
| NAICS | 622110 — General Medical and Surgical Hospitals |
| PSC | Q201 — MEDICAL- MANAGED HEALTHCARE |
| Parent award / vehicle | HT005018D0034 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.8M |
| Current contract value | $2.8M |
| Potential contract value / ceiling | $2.8M |
| Start date | Apr 1, 2019 |
| Current end date | Sep 30, 2023 |
| Potential end date | Sep 30, 2023 |
| Latest award activity | Sep 19, 2023 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 19, 2023 | P00014 | $-62.9K | 4 FTE PHARMACISTS |
| Apr 21, 2023 | P00013 | $-59.0K | 4 FTE PHARMACISTS |
| Oct 1, 2022 | P00012 | $678.9K | 4 FTE PHARMACISTS |
| May 23, 2022 | P00011 | $0 | 4 FTE PHARMACISTS |
| Jan 6, 2022 | P00010 | $-56.8K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Oct 1, 2021 | P00009 | $668.8K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Jul 1, 2021 | P00008 | $0 | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Oct 1, 2020 | P00007 | $658.9K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| May 21, 2020 | P00006 | $-44.8K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| May 14, 2020 | P00005 | $0 | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Oct 15, 2019 | P00004 | $0 | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Oct 1, 2019 | P00003 | $649.2K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Sep 14, 2019 | P00002 | $0 | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Mar 22, 2019 | 0 | $331.1K | 4 FULL TIME EQUIVALENT PHARMACISTS |
| Mar 22, 2019 | P00001 | $0 | 4 FULL TIME EQUIVALENT PHARMACISTS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.